nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—AOX1—Mercaptopurine—hematologic cancer	0.0605	0.101	CbGbCtD
Perphenazine—CYP2C18—Ifosfamide—hematologic cancer	0.038	0.0638	CbGbCtD
Perphenazine—CYP1A2—Anagrelide—hematologic cancer	0.0216	0.0363	CbGbCtD
Perphenazine—CYP2B6—Thiotepa—hematologic cancer	0.0212	0.0356	CbGbCtD
Perphenazine—AOX1—Methotrexate—hematologic cancer	0.0198	0.0332	CbGbCtD
Perphenazine—CYP2C9—Bexarotene—hematologic cancer	0.0135	0.0227	CbGbCtD
Perphenazine—CYP2B6—Ifosfamide—hematologic cancer	0.012	0.0202	CbGbCtD
Perphenazine—CYP2C8—Bortezomib—hematologic cancer	0.0119	0.0199	CbGbCtD
Perphenazine—CYP2D6—Lomustine—hematologic cancer	0.0115	0.0193	CbGbCtD
Perphenazine—CYP1A2—Carmustine—hematologic cancer	0.0114	0.0191	CbGbCtD
Perphenazine—CYP2C9—Idarubicin—hematologic cancer	0.0112	0.0188	CbGbCtD
Perphenazine—CYP2B6—Nilotinib—hematologic cancer	0.0104	0.0175	CbGbCtD
Perphenazine—CYP2D6—Idarubicin—hematologic cancer	0.0102	0.0172	CbGbCtD
Perphenazine—CYP2C19—Bortezomib—hematologic cancer	0.00996	0.0167	CbGbCtD
Perphenazine—CYP1A2—Methoxsalen—hematologic cancer	0.00966	0.0162	CbGbCtD
Perphenazine—CYP1A2—Bortezomib—hematologic cancer	0.00919	0.0154	CbGbCtD
Perphenazine—CYP2C8—Ifosfamide—hematologic cancer	0.00911	0.0153	CbGbCtD
Perphenazine—CYP1A2—Daunorubicin—hematologic cancer	0.00879	0.0148	CbGbCtD
Perphenazine—CYP2D6—Hydroxyurea—hematologic cancer	0.00871	0.0146	CbGbCtD
Perphenazine—CYP2C19—Thalidomide—hematologic cancer	0.00868	0.0146	CbGbCtD
Perphenazine—CYP1A2—Alitretinoin—hematologic cancer	0.00861	0.0145	CbGbCtD
Perphenazine—CYP2C9—Bortezomib—hematologic cancer	0.00828	0.0139	CbGbCtD
Perphenazine—CYP2C19—Teniposide—hematologic cancer	0.00828	0.0139	CbGbCtD
Perphenazine—CYP1A2—Thalidomide—hematologic cancer	0.00801	0.0134	CbGbCtD
Perphenazine—CYP2C8—Nilotinib—hematologic cancer	0.00791	0.0133	CbGbCtD
Perphenazine—CYP3A4—Bexarotene—hematologic cancer	0.00786	0.0132	CbGbCtD
Perphenazine—CYP2C19—Ifosfamide—hematologic cancer	0.00764	0.0128	CbGbCtD
Perphenazine—CYP2D6—Bortezomib—hematologic cancer	0.00757	0.0127	CbGbCtD
Perphenazine—CYP3A4—Lomustine—hematologic cancer	0.0073	0.0123	CbGbCtD
Perphenazine—CYP3A4—Busulfan—hematologic cancer	0.0073	0.0123	CbGbCtD
Perphenazine—CYP2C19—Imatinib—hematologic cancer	0.0073	0.0122	CbGbCtD
Perphenazine—CYP2C9—Thalidomide—hematologic cancer	0.00722	0.0121	CbGbCtD
Perphenazine—CYP2B6—Irinotecan—hematologic cancer	0.00717	0.012	CbGbCtD
Perphenazine—CYP1A2—Dacarbazine—hematologic cancer	0.00689	0.0116	CbGbCtD
Perphenazine—CYP2C9—Teniposide—hematologic cancer	0.00688	0.0116	CbGbCtD
Perphenazine—CYP1A2—Imatinib—hematologic cancer	0.00673	0.0113	CbGbCtD
Perphenazine—CYP3A4—Thiotepa—hematologic cancer	0.00651	0.0109	CbGbCtD
Perphenazine—CYP2C9—Ifosfamide—hematologic cancer	0.00635	0.0107	CbGbCtD
Perphenazine—CYP2C9—Imatinib—hematologic cancer	0.00607	0.0102	CbGbCtD
Perphenazine—CYP2B6—Cisplatin—hematologic cancer	0.00585	0.00982	CbGbCtD
Perphenazine—CYP2D6—Imatinib—hematologic cancer	0.00555	0.00931	CbGbCtD
Perphenazine—CYP2C9—Nilotinib—hematologic cancer	0.00551	0.00925	CbGbCtD
Perphenazine—CYP1A2—Dasatinib—hematologic cancer	0.00541	0.00908	CbGbCtD
Perphenazine—CYP3A4—Methoxsalen—hematologic cancer	0.00506	0.0085	CbGbCtD
Perphenazine—CYP2D6—Nilotinib—hematologic cancer	0.00504	0.00846	CbGbCtD
Perphenazine—CYP2D6—Vinorelbine—hematologic cancer	0.005	0.00839	CbGbCtD
Perphenazine—CYP3A4—Bortezomib—hematologic cancer	0.00482	0.00808	CbGbCtD
Perphenazine—CYP2C19—Prednisone—hematologic cancer	0.00481	0.00807	CbGbCtD
Perphenazine—CYP2B6—Dexamethasone—hematologic cancer	0.00472	0.00793	CbGbCtD
Perphenazine—CYP3A4—Daunorubicin—hematologic cancer	0.00461	0.00773	CbGbCtD
Perphenazine—CYP2C8—Etoposide—hematologic cancer	0.00435	0.0073	CbGbCtD
Perphenazine—CYP3A4—Cytarabine—hematologic cancer	0.00406	0.00682	CbGbCtD
Perphenazine—CYP3A4—Teniposide—hematologic cancer	0.004	0.00672	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—hematologic cancer	0.00392	0.00658	CbGbCtD
Perphenazine—CYP3A4—Ifosfamide—hematologic cancer	0.00369	0.0062	CbGbCtD
Perphenazine—CYP2C8—Dexamethasone—hematologic cancer	0.00358	0.00601	CbGbCtD
Perphenazine—CYP3A4—Imatinib—hematologic cancer	0.00353	0.00592	CbGbCtD
Perphenazine—CYP1A2—Etoposide—hematologic cancer	0.00337	0.00565	CbGbCtD
Perphenazine—CYP3A4—Ruxolitinib—hematologic cancer	0.00332	0.00558	CbGbCtD
Perphenazine—CYP3A4—Nilotinib—hematologic cancer	0.00321	0.00538	CbGbCtD
Perphenazine—CYP3A4—Vinorelbine—hematologic cancer	0.00318	0.00534	CbGbCtD
Perphenazine—CYP2C9—Cisplatin—hematologic cancer	0.00309	0.00519	CbGbCtD
Perphenazine—CYP2D6—Vinblastine—hematologic cancer	0.00308	0.00517	CbGbCtD
Perphenazine—CYP2C19—Dexamethasone—hematologic cancer	0.003	0.00504	CbGbCtD
Perphenazine—CYP3A4—Triamcinolone—hematologic cancer	0.00291	0.00488	CbGbCtD
Perphenazine—CYP3A4—Dasatinib—hematologic cancer	0.00283	0.00476	CbGbCtD
Perphenazine—CYP3A4—Mitoxantrone—hematologic cancer	0.0028	0.0047	CbGbCtD
Perphenazine—CYP2C9—Dexamethasone—hematologic cancer	0.0025	0.00419	CbGbCtD
Perphenazine—CYP3A4—Betamethasone—hematologic cancer	0.00249	0.00419	CbGbCtD
Perphenazine—CYP3A4—Prednisolone—hematologic cancer	0.00246	0.00413	CbGbCtD
Perphenazine—CYP3A4—Prednisone—hematologic cancer	0.00232	0.0039	CbGbCtD
Perphenazine—CYP2D6—Dexamethasone—hematologic cancer	0.00228	0.00383	CbGbCtD
Perphenazine—CYP3A4—Irinotecan—hematologic cancer	0.0022	0.0037	CbGbCtD
Perphenazine—CYP3A4—Vinblastine—hematologic cancer	0.00196	0.00329	CbGbCtD
Perphenazine—CYP3A4—Vincristine—hematologic cancer	0.00193	0.00323	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—hematologic cancer	0.00189	0.00318	CbGbCtD
Perphenazine—CYP3A4—Etoposide—hematologic cancer	0.00177	0.00296	CbGbCtD
Perphenazine—CYP3A4—Dexamethasone—hematologic cancer	0.00145	0.00244	CbGbCtD
Perphenazine—CYP3A4—Doxorubicin—hematologic cancer	0.0012	0.00202	CbGbCtD
Perphenazine—AOX1—gonad—hematologic cancer	0.000873	0.0272	CbGeAlD
Perphenazine—HTR1A—hematopoietic system—hematologic cancer	0.000826	0.0258	CbGeAlD
Perphenazine—CALM2—hematopoietic system—hematologic cancer	0.000812	0.0253	CbGeAlD
Perphenazine—CALM1—hematopoietic system—hematologic cancer	0.000808	0.0252	CbGeAlD
Perphenazine—HTR7—hematopoietic system—hematologic cancer	0.000789	0.0246	CbGeAlD
Perphenazine—CYP2C19—hematopoietic system—hematologic cancer	0.000771	0.0241	CbGeAlD
Perphenazine—CALM3—blood—hematologic cancer	0.000685	0.0214	CbGeAlD
Perphenazine—CYP2C8—hematopoietic system—hematologic cancer	0.000673	0.021	CbGeAlD
Perphenazine—AOX1—lung—hematologic cancer	0.000667	0.0208	CbGeAlD
Perphenazine—CALM3—bone marrow—hematologic cancer	0.000663	0.0207	CbGeAlD
Perphenazine—CYP1A2—hematopoietic system—hematologic cancer	0.00063	0.0196	CbGeAlD
Perphenazine—AOX1—testis—hematologic cancer	0.000629	0.0196	CbGeAlD
Perphenazine—CALM2—gonad—hematologic cancer	0.000617	0.0193	CbGeAlD
Perphenazine—CALM1—gonad—hematologic cancer	0.000614	0.0192	CbGeAlD
Perphenazine—CYP2B6—hematopoietic system—hematologic cancer	0.000604	0.0188	CbGeAlD
Perphenazine—CALM3—lung—hematologic cancer	0.0006	0.0187	CbGeAlD
Perphenazine—HTR7—gonad—hematologic cancer	0.0006	0.0187	CbGeAlD
Perphenazine—CYP2C9—hematopoietic system—hematologic cancer	0.000598	0.0187	CbGeAlD
Perphenazine—HRH1—hematopoietic system—hematologic cancer	0.000589	0.0184	CbGeAlD
Perphenazine—ADRA2A—hematopoietic system—hematologic cancer	0.000579	0.0181	CbGeAlD
Perphenazine—CALM3—testis—hematologic cancer	0.000567	0.0177	CbGeAlD
Perphenazine—CALM2—blood—hematologic cancer	0.000538	0.0168	CbGeAlD
Perphenazine—CALM1—blood—hematologic cancer	0.000535	0.0167	CbGeAlD
Perphenazine—HTR7—blood—hematologic cancer	0.000523	0.0163	CbGeAlD
Perphenazine—CALM2—bone marrow—hematologic cancer	0.00052	0.0162	CbGeAlD
Perphenazine—CALM1—bone marrow—hematologic cancer	0.000518	0.0162	CbGeAlD
Perphenazine—Aripiprazole—H1F0—hematologic cancer	0.000518	0.192	CrCbGaD
Perphenazine—CYP2C19—blood—hematologic cancer	0.000511	0.0159	CbGeAlD
Perphenazine—HTR2A—hematopoietic system—hematologic cancer	0.000492	0.0154	CbGeAlD
Perphenazine—CALM2—lung—hematologic cancer	0.000472	0.0147	CbGeAlD
Perphenazine—CALM1—lung—hematologic cancer	0.000469	0.0146	CbGeAlD
Perphenazine—CYP2B6—gonad—hematologic cancer	0.000459	0.0143	CbGeAlD
Perphenazine—HTR7—lung—hematologic cancer	0.000459	0.0143	CbGeAlD
Perphenazine—AOX1—lymph node—hematologic cancer	0.000456	0.0142	CbGeAlD
Perphenazine—CYP3A4—hematopoietic system—hematologic cancer	0.000456	0.0142	CbGeAlD
Perphenazine—CYP2D6—hematopoietic system—hematologic cancer	0.000448	0.014	CbGeAlD
Perphenazine—CYP2C8—blood—hematologic cancer	0.000446	0.0139	CbGeAlD
Perphenazine—CALM2—testis—hematologic cancer	0.000445	0.0139	CbGeAlD
Perphenazine—CALM1—testis—hematologic cancer	0.000443	0.0138	CbGeAlD
Perphenazine—ADRA2A—gonad—hematologic cancer	0.00044	0.0137	CbGeAlD
Perphenazine—DRD2—lung—hematologic cancer	0.000434	0.0135	CbGeAlD
Perphenazine—HTR7—testis—hematologic cancer	0.000433	0.0135	CbGeAlD
Perphenazine—CYP1A2—blood—hematologic cancer	0.000417	0.013	CbGeAlD
Perphenazine—CALM3—lymph node—hematologic cancer	0.000411	0.0128	CbGeAlD
Perphenazine—DRD2—testis—hematologic cancer	0.000409	0.0128	CbGeAlD
Perphenazine—CYP2B6—blood—hematologic cancer	0.0004	0.0125	CbGeAlD
Perphenazine—CYP2C9—blood—hematologic cancer	0.000396	0.0124	CbGeAlD
Perphenazine—ADRA2A—blood—hematologic cancer	0.000384	0.012	CbGeAlD
Perphenazine—HTR2A—gonad—hematologic cancer	0.000374	0.0117	CbGeAlD
Perphenazine—CYP2C8—testis—hematologic cancer	0.000369	0.0115	CbGeAlD
Perphenazine—CYP1A2—lung—hematologic cancer	0.000366	0.0114	CbGeAlD
Perphenazine—CYP2B6—lung—hematologic cancer	0.000351	0.0109	CbGeAlD
Perphenazine—HRH1—lung—hematologic cancer	0.000342	0.0107	CbGeAlD
Perphenazine—ADRA2A—lung—hematologic cancer	0.000336	0.0105	CbGeAlD
Perphenazine—CYP2B6—testis—hematologic cancer	0.000331	0.0103	CbGeAlD
Perphenazine—HTR2A—blood—hematologic cancer	0.000326	0.0102	CbGeAlD
Perphenazine—Quetiapine—H1F0—hematologic cancer	0.000324	0.12	CrCbGaD
Perphenazine—HRH1—testis—hematologic cancer	0.000323	0.0101	CbGeAlD
Perphenazine—CALM2—lymph node—hematologic cancer	0.000323	0.0101	CbGeAlD
Perphenazine—CALM1—lymph node—hematologic cancer	0.000321	0.01	CbGeAlD
Perphenazine—ADRA2A—testis—hematologic cancer	0.000317	0.0099	CbGeAlD
Perphenazine—CYP3A4—blood—hematologic cancer	0.000302	0.00942	CbGeAlD
Perphenazine—CYP2D6—blood—hematologic cancer	0.000297	0.00927	CbGeAlD
Perphenazine—HTR2A—lung—hematologic cancer	0.000286	0.00892	CbGeAlD
Perphenazine—HTR2A—testis—hematologic cancer	0.00027	0.00842	CbGeAlD
Perphenazine—CYP2D6—testis—hematologic cancer	0.000246	0.00767	CbGeAlD
Perphenazine—HRH1—lymph node—hematologic cancer	0.000234	0.00731	CbGeAlD
Perphenazine—ADRA2A—lymph node—hematologic cancer	0.00023	0.00718	CbGeAlD
Perphenazine—Acepromazine—SLC22A1—hematologic cancer	0.000178	0.066	CrCbGaD
Perphenazine—Thioproperazine—SLC22A1—hematologic cancer	0.000174	0.0645	CrCbGaD
Perphenazine—Pipotiazine—SLC22A1—hematologic cancer	0.000172	0.0635	CrCbGaD
Perphenazine—Thiothixene—SLC22A1—hematologic cancer	0.000172	0.0635	CrCbGaD
Perphenazine—Clomipramine—GSTP1—hematologic cancer	0.000147	0.0543	CrCbGaD
Perphenazine—Flupentixol—ABCB1—hematologic cancer	0.000103	0.0381	CrCbGaD
Perphenazine—Chlorpromazine—SLC22A1—hematologic cancer	9.3e-05	0.0344	CrCbGaD
Perphenazine—Domperidone—ABCB1—hematologic cancer	6.93e-05	0.0256	CrCbGaD
Perphenazine—Nefazodone—ABCB1—hematologic cancer	5.75e-05	0.0213	CrCbGaD
Perphenazine—Triflupromazine—ABCB1—hematologic cancer	5.61e-05	0.0207	CrCbGaD
Perphenazine—Acepromazine—ALB—hematologic cancer	5.44e-05	0.0201	CrCbGaD
Perphenazine—Aripiprazole—ABCB1—hematologic cancer	5.35e-05	0.0198	CrCbGaD
Perphenazine—Trazodone—ABCB1—hematologic cancer	5.32e-05	0.0197	CrCbGaD
Perphenazine—Thioproperazine—ALB—hematologic cancer	5.31e-05	0.0197	CrCbGaD
Perphenazine—Urticaria—Mitoxantrone—hematologic cancer	5.26e-05	0.000248	CcSEcCtD
Perphenazine—Anorexia—Etoposide—hematologic cancer	5.25e-05	0.000247	CcSEcCtD
Perphenazine—Hypersensitivity—Carmustine—hematologic cancer	5.25e-05	0.000247	CcSEcCtD
Perphenazine—Pruritus—Thalidomide—hematologic cancer	5.25e-05	0.000247	CcSEcCtD
Perphenazine—Diarrhoea—Thiotepa—hematologic cancer	5.25e-05	0.000247	CcSEcCtD
Perphenazine—Body temperature increased—Irinotecan—hematologic cancer	5.24e-05	0.000247	CcSEcCtD
Perphenazine—Body temperature increased—Mitoxantrone—hematologic cancer	5.24e-05	0.000247	CcSEcCtD
Perphenazine—Decreased appetite—Cisplatin—hematologic cancer	5.23e-05	0.000246	CcSEcCtD
Perphenazine—Thiothixene—ALB—hematologic cancer	5.23e-05	0.0193	CrCbGaD
Perphenazine—Pipotiazine—ALB—hematologic cancer	5.23e-05	0.0193	CrCbGaD
Perphenazine—Hypersensitivity—Alitretinoin—hematologic cancer	5.2e-05	0.000245	CcSEcCtD
Perphenazine—Drowsiness—Methotrexate—hematologic cancer	5.18e-05	0.000244	CcSEcCtD
Perphenazine—Pancytopenia—Epirubicin—hematologic cancer	5.16e-05	0.000243	CcSEcCtD
Perphenazine—Headache—Bortezomib—hematologic cancer	5.15e-05	0.000243	CcSEcCtD
Perphenazine—Hypotension—Etoposide—hematologic cancer	5.15e-05	0.000242	CcSEcCtD
Perphenazine—Pain—Cisplatin—hematologic cancer	5.14e-05	0.000242	CcSEcCtD
Perphenazine—Hypersensitivity—Ifosfamide—hematologic cancer	5.14e-05	0.000242	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—hematologic cancer	5.13e-05	0.000242	CcSEcCtD
Perphenazine—Body temperature increased—Gemcitabine—hematologic cancer	5.1e-05	0.00024	CcSEcCtD
Perphenazine—Dry mouth—Triamcinolone—hematologic cancer	5.1e-05	0.00024	CcSEcCtD
Perphenazine—Angioedema—Betamethasone—hematologic cancer	5.08e-05	0.000239	CcSEcCtD
Perphenazine—Angioedema—Dexamethasone—hematologic cancer	5.08e-05	0.000239	CcSEcCtD
Perphenazine—Diarrhoea—Thalidomide—hematologic cancer	5.08e-05	0.000239	CcSEcCtD
Perphenazine—Dizziness—Thiotepa—hematologic cancer	5.07e-05	0.000239	CcSEcCtD
Perphenazine—Headache—Vinorelbine—hematologic cancer	5.03e-05	0.000237	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—hematologic cancer	5.03e-05	0.000237	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—hematologic cancer	5.03e-05	0.000237	CcSEcCtD
Perphenazine—Hypersensitivity—Vincristine—hematologic cancer	5.01e-05	0.000236	CcSEcCtD
Perphenazine—Anaphylactic shock—Triamcinolone—hematologic cancer	5e-05	0.000235	CcSEcCtD
Perphenazine—Pruritus—Alitretinoin—hematologic cancer	4.99e-05	0.000235	CcSEcCtD
Perphenazine—Syncope—Betamethasone—hematologic cancer	4.98e-05	0.000235	CcSEcCtD
Perphenazine—Syncope—Dexamethasone—hematologic cancer	4.98e-05	0.000235	CcSEcCtD
Perphenazine—Eosinophilia—Doxorubicin—hematologic cancer	4.98e-05	0.000234	CcSEcCtD
Perphenazine—Infection—Triamcinolone—hematologic cancer	4.97e-05	0.000234	CcSEcCtD
Perphenazine—Photosensitivity reaction—Epirubicin—hematologic cancer	4.96e-05	0.000233	CcSEcCtD
Perphenazine—Pruritus—Ifosfamide—hematologic cancer	4.94e-05	0.000232	CcSEcCtD
Perphenazine—Shock—Triamcinolone—hematologic cancer	4.92e-05	0.000232	CcSEcCtD
Perphenazine—Insomnia—Prednisolone—hematologic cancer	4.92e-05	0.000232	CcSEcCtD
Perphenazine—Dyspnoea—Etoposide—hematologic cancer	4.91e-05	0.000231	CcSEcCtD
Perphenazine—Dizziness—Thalidomide—hematologic cancer	4.91e-05	0.000231	CcSEcCtD
Perphenazine—Hyperglycaemia—Epirubicin—hematologic cancer	4.9e-05	0.000231	CcSEcCtD
Perphenazine—Somnolence—Etoposide—hematologic cancer	4.9e-05	0.000231	CcSEcCtD
Perphenazine—Loss of consciousness—Betamethasone—hematologic cancer	4.88e-05	0.00023	CcSEcCtD
Perphenazine—Loss of consciousness—Dexamethasone—hematologic cancer	4.88e-05	0.00023	CcSEcCtD
Perphenazine—Hypersensitivity—Mitoxantrone—hematologic cancer	4.88e-05	0.00023	CcSEcCtD
Perphenazine—Hypersensitivity—Irinotecan—hematologic cancer	4.88e-05	0.00023	CcSEcCtD
Perphenazine—Tachycardia—Triamcinolone—hematologic cancer	4.88e-05	0.00023	CcSEcCtD
Perphenazine—Diarrhoea—Carmustine—hematologic cancer	4.88e-05	0.00023	CcSEcCtD
Perphenazine—Drowsiness—Epirubicin—hematologic cancer	4.84e-05	0.000228	CcSEcCtD
Perphenazine—Erythema—Prednisone—hematologic cancer	4.84e-05	0.000228	CcSEcCtD
Perphenazine—Diarrhoea—Alitretinoin—hematologic cancer	4.83e-05	0.000227	CcSEcCtD
Perphenazine—Agranulocytosis—Methotrexate—hematologic cancer	4.83e-05	0.000227	CcSEcCtD
Perphenazine—Convulsion—Dexamethasone—hematologic cancer	4.81e-05	0.000227	CcSEcCtD
Perphenazine—Convulsion—Betamethasone—hematologic cancer	4.81e-05	0.000227	CcSEcCtD
Perphenazine—Headache—Thiotepa—hematologic cancer	4.81e-05	0.000226	CcSEcCtD
Perphenazine—Hypertension—Dexamethasone—hematologic cancer	4.8e-05	0.000226	CcSEcCtD
Perphenazine—Hypertension—Betamethasone—hematologic cancer	4.8e-05	0.000226	CcSEcCtD
Perphenazine—Decreased appetite—Etoposide—hematologic cancer	4.79e-05	0.000226	CcSEcCtD
Perphenazine—Diarrhoea—Ifosfamide—hematologic cancer	4.77e-05	0.000225	CcSEcCtD
Perphenazine—Pancytopenia—Doxorubicin—hematologic cancer	4.77e-05	0.000225	CcSEcCtD
Perphenazine—Body temperature increased—Cisplatin—hematologic cancer	4.75e-05	0.000224	CcSEcCtD
Perphenazine—Jaundice—Epirubicin—hematologic cancer	4.72e-05	0.000222	CcSEcCtD
Perphenazine—Dizziness—Carmustine—hematologic cancer	4.71e-05	0.000222	CcSEcCtD
Perphenazine—Pain—Etoposide—hematologic cancer	4.71e-05	0.000222	CcSEcCtD
Perphenazine—Constipation—Etoposide—hematologic cancer	4.71e-05	0.000222	CcSEcCtD
Perphenazine—Dizziness—Alitretinoin—hematologic cancer	4.67e-05	0.00022	CcSEcCtD
Perphenazine—Diarrhoea—Vincristine—hematologic cancer	4.65e-05	0.000219	CcSEcCtD
Perphenazine—Headache—Thalidomide—hematologic cancer	4.65e-05	0.000219	CcSEcCtD
Perphenazine—Pain—Prednisolone—hematologic cancer	4.65e-05	0.000219	CcSEcCtD
Perphenazine—Dizziness—Ifosfamide—hematologic cancer	4.61e-05	0.000217	CcSEcCtD
Perphenazine—Photosensitivity reaction—Doxorubicin—hematologic cancer	4.59e-05	0.000216	CcSEcCtD
Perphenazine—Pruritus—Gemcitabine—hematologic cancer	4.57e-05	0.000215	CcSEcCtD
Perphenazine—Vision blurred—Prednisone—hematologic cancer	4.56e-05	0.000215	CcSEcCtD
Perphenazine—Anaphylactic shock—Dexamethasone—hematologic cancer	4.53e-05	0.000214	CcSEcCtD
Perphenazine—Anaphylactic shock—Betamethasone—hematologic cancer	4.53e-05	0.000214	CcSEcCtD
Perphenazine—Hyperglycaemia—Doxorubicin—hematologic cancer	4.53e-05	0.000214	CcSEcCtD
Perphenazine—Diarrhoea—Mitoxantrone—hematologic cancer	4.53e-05	0.000213	CcSEcCtD
Perphenazine—Diarrhoea—Irinotecan—hematologic cancer	4.53e-05	0.000213	CcSEcCtD
Perphenazine—Insomnia—Triamcinolone—hematologic cancer	4.52e-05	0.000213	CcSEcCtD
Perphenazine—Agranulocytosis—Epirubicin—hematologic cancer	4.52e-05	0.000213	CcSEcCtD
Perphenazine—Infection—Dexamethasone—hematologic cancer	4.51e-05	0.000212	CcSEcCtD
Perphenazine—Infection—Betamethasone—hematologic cancer	4.51e-05	0.000212	CcSEcCtD
Perphenazine—Dizziness—Vincristine—hematologic cancer	4.5e-05	0.000212	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—hematologic cancer	4.48e-05	0.000211	CcSEcCtD
Perphenazine—Headache—Carmustine—hematologic cancer	4.46e-05	0.00021	CcSEcCtD
Perphenazine—Shock—Betamethasone—hematologic cancer	4.46e-05	0.00021	CcSEcCtD
Perphenazine—Shock—Dexamethasone—hematologic cancer	4.46e-05	0.00021	CcSEcCtD
Perphenazine—Dyspnoea—Triamcinolone—hematologic cancer	4.46e-05	0.00021	CcSEcCtD
Perphenazine—Agitation—Prednisone—hematologic cancer	4.45e-05	0.000209	CcSEcCtD
Perphenazine—Hypersensitivity—Cisplatin—hematologic cancer	4.43e-05	0.000209	CcSEcCtD
Perphenazine—Tachycardia—Dexamethasone—hematologic cancer	4.43e-05	0.000208	CcSEcCtD
Perphenazine—Tachycardia—Betamethasone—hematologic cancer	4.43e-05	0.000208	CcSEcCtD
Perphenazine—Bradycardia—Epirubicin—hematologic cancer	4.43e-05	0.000208	CcSEcCtD
Perphenazine—Headache—Alitretinoin—hematologic cancer	4.42e-05	0.000208	CcSEcCtD
Perphenazine—Angioedema—Prednisone—hematologic cancer	4.42e-05	0.000208	CcSEcCtD
Perphenazine—Diarrhoea—Gemcitabine—hematologic cancer	4.42e-05	0.000208	CcSEcCtD
Perphenazine—Dizziness—Irinotecan—hematologic cancer	4.38e-05	0.000206	CcSEcCtD
Perphenazine—Urticaria—Etoposide—hematologic cancer	4.38e-05	0.000206	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—hematologic cancer	4.37e-05	0.000206	CcSEcCtD
Perphenazine—Body temperature increased—Etoposide—hematologic cancer	4.36e-05	0.000205	CcSEcCtD
Perphenazine—Syncope—Prednisone—hematologic cancer	4.34e-05	0.000204	CcSEcCtD
Perphenazine—Hypoaesthesia—Epirubicin—hematologic cancer	4.33e-05	0.000204	CcSEcCtD
Perphenazine—Anorexia—Dexamethasone—hematologic cancer	4.32e-05	0.000204	CcSEcCtD
Perphenazine—Anorexia—Betamethasone—hematologic cancer	4.32e-05	0.000204	CcSEcCtD
Perphenazine—Urticaria—Prednisolone—hematologic cancer	4.32e-05	0.000203	CcSEcCtD
Perphenazine—Fluphenazine—ABCB1—hematologic cancer	4.31e-05	0.016	CrCbGaD
Perphenazine—Oedema peripheral—Epirubicin—hematologic cancer	4.28e-05	0.000202	CcSEcCtD
Perphenazine—Pain—Triamcinolone—hematologic cancer	4.27e-05	0.000201	CcSEcCtD
Perphenazine—Headache—Vincristine—hematologic cancer	4.26e-05	0.000201	CcSEcCtD
Perphenazine—Loss of consciousness—Prednisone—hematologic cancer	4.25e-05	0.0002	CcSEcCtD
Perphenazine—Hypotension—Dexamethasone—hematologic cancer	4.24e-05	0.0002	CcSEcCtD
Perphenazine—Hypotension—Betamethasone—hematologic cancer	4.24e-05	0.0002	CcSEcCtD
Perphenazine—Convulsion—Prednisone—hematologic cancer	4.19e-05	0.000197	CcSEcCtD
Perphenazine—Agranulocytosis—Doxorubicin—hematologic cancer	4.18e-05	0.000197	CcSEcCtD
Perphenazine—Hypertension—Prednisone—hematologic cancer	4.18e-05	0.000197	CcSEcCtD
Perphenazine—Headache—Mitoxantrone—hematologic cancer	4.15e-05	0.000195	CcSEcCtD
Perphenazine—Headache—Irinotecan—hematologic cancer	4.15e-05	0.000195	CcSEcCtD
Perphenazine—Clomipramine—ALB—hematologic cancer	4.13e-05	0.0153	CrCbGaD
Perphenazine—Diarrhoea—Cisplatin—hematologic cancer	4.12e-05	0.000194	CcSEcCtD
Perphenazine—Insomnia—Betamethasone—hematologic cancer	4.1e-05	0.000193	CcSEcCtD
Perphenazine—Insomnia—Dexamethasone—hematologic cancer	4.1e-05	0.000193	CcSEcCtD
Perphenazine—Bradycardia—Doxorubicin—hematologic cancer	4.1e-05	0.000193	CcSEcCtD
Perphenazine—Hypersensitivity—Etoposide—hematologic cancer	4.06e-05	0.000191	CcSEcCtD
Perphenazine—Erythema—Methotrexate—hematologic cancer	4.04e-05	0.00019	CcSEcCtD
Perphenazine—Headache—Gemcitabine—hematologic cancer	4.04e-05	0.00019	CcSEcCtD
Perphenazine—Hypersensitivity—Prednisolone—hematologic cancer	4e-05	0.000189	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—hematologic cancer	4e-05	0.000189	CcSEcCtD
Perphenazine—Urticaria—Triamcinolone—hematologic cancer	3.97e-05	0.000187	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—hematologic cancer	3.96e-05	0.000187	CcSEcCtD
Perphenazine—Body temperature increased—Triamcinolone—hematologic cancer	3.95e-05	0.000186	CcSEcCtD
Perphenazine—Anaphylactic shock—Prednisone—hematologic cancer	3.95e-05	0.000186	CcSEcCtD
Perphenazine—Clomipramine—ABCB1—hematologic cancer	3.94e-05	0.0146	CrCbGaD
Perphenazine—Decreased appetite—Betamethasone—hematologic cancer	3.94e-05	0.000186	CcSEcCtD
Perphenazine—Decreased appetite—Dexamethasone—hematologic cancer	3.94e-05	0.000186	CcSEcCtD
Perphenazine—Chlorprothixene—ABCB1—hematologic cancer	3.93e-05	0.0145	CrCbGaD
Perphenazine—Infection—Prednisone—hematologic cancer	3.92e-05	0.000185	CcSEcCtD
Perphenazine—Pruritus—Etoposide—hematologic cancer	3.9e-05	0.000184	CcSEcCtD
Perphenazine—Shock—Prednisone—hematologic cancer	3.89e-05	0.000183	CcSEcCtD
Perphenazine—Pain—Dexamethasone—hematologic cancer	3.88e-05	0.000183	CcSEcCtD
Perphenazine—Pain—Betamethasone—hematologic cancer	3.88e-05	0.000183	CcSEcCtD
Perphenazine—Tachycardia—Prednisone—hematologic cancer	3.85e-05	0.000182	CcSEcCtD
Perphenazine—Vision blurred—Methotrexate—hematologic cancer	3.81e-05	0.00018	CcSEcCtD
Perphenazine—Erythema—Epirubicin—hematologic cancer	3.78e-05	0.000178	CcSEcCtD
Perphenazine—Diarrhoea—Etoposide—hematologic cancer	3.77e-05	0.000178	CcSEcCtD
Perphenazine—Anorexia—Prednisone—hematologic cancer	3.76e-05	0.000177	CcSEcCtD
Perphenazine—Hypersensitivity—Triamcinolone—hematologic cancer	3.68e-05	0.000173	CcSEcCtD
Perphenazine—Dizziness—Etoposide—hematologic cancer	3.64e-05	0.000172	CcSEcCtD
Perphenazine—Muscle spasms—Epirubicin—hematologic cancer	3.64e-05	0.000171	CcSEcCtD
Perphenazine—Leukopenia—Methotrexate—hematologic cancer	3.62e-05	0.00017	CcSEcCtD
Perphenazine—Urticaria—Betamethasone—hematologic cancer	3.6e-05	0.00017	CcSEcCtD
Perphenazine—Urticaria—Dexamethasone—hematologic cancer	3.6e-05	0.00017	CcSEcCtD
Perphenazine—Dizziness—Prednisolone—hematologic cancer	3.59e-05	0.000169	CcSEcCtD
Perphenazine—Body temperature increased—Betamethasone—hematologic cancer	3.58e-05	0.000169	CcSEcCtD
Perphenazine—Body temperature increased—Dexamethasone—hematologic cancer	3.58e-05	0.000169	CcSEcCtD
Perphenazine—Insomnia—Prednisone—hematologic cancer	3.57e-05	0.000168	CcSEcCtD
Perphenazine—Vision blurred—Epirubicin—hematologic cancer	3.57e-05	0.000168	CcSEcCtD
Perphenazine—Pruritus—Triamcinolone—hematologic cancer	3.54e-05	0.000167	CcSEcCtD
Perphenazine—Cough—Methotrexate—hematologic cancer	3.53e-05	0.000166	CcSEcCtD
Perphenazine—Convulsion—Methotrexate—hematologic cancer	3.5e-05	0.000165	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—hematologic cancer	3.5e-05	0.000165	CcSEcCtD
Perphenazine—Promethazine—ABCB1—hematologic cancer	3.49e-05	0.0129	CrCbGaD
Perphenazine—Agitation—Epirubicin—hematologic cancer	3.48e-05	0.000164	CcSEcCtD
Perphenazine—Headache—Etoposide—hematologic cancer	3.45e-05	0.000163	CcSEcCtD
Perphenazine—Trifluoperazine—ABCB1—hematologic cancer	3.45e-05	0.0128	CrCbGaD
Perphenazine—Decreased appetite—Prednisone—hematologic cancer	3.43e-05	0.000162	CcSEcCtD
Perphenazine—Headache—Prednisolone—hematologic cancer	3.4e-05	0.00016	CcSEcCtD
Perphenazine—Syncope—Epirubicin—hematologic cancer	3.39e-05	0.00016	CcSEcCtD
Perphenazine—Leukopenia—Epirubicin—hematologic cancer	3.39e-05	0.00016	CcSEcCtD
Perphenazine—Constipation—Prednisone—hematologic cancer	3.38e-05	0.000159	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—hematologic cancer	3.37e-05	0.000159	CcSEcCtD
Perphenazine—Quetiapine—ABCB1—hematologic cancer	3.34e-05	0.0124	CrCbGaD
Perphenazine—Confusional state—Methotrexate—hematologic cancer	3.33e-05	0.000157	CcSEcCtD
Perphenazine—Loss of consciousness—Epirubicin—hematologic cancer	3.33e-05	0.000157	CcSEcCtD
Perphenazine—Dizziness—Triamcinolone—hematologic cancer	3.31e-05	0.000156	CcSEcCtD
Perphenazine—Cough—Epirubicin—hematologic cancer	3.3e-05	0.000156	CcSEcCtD
Perphenazine—Anaphylactic shock—Methotrexate—hematologic cancer	3.3e-05	0.000155	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—hematologic cancer	3.3e-05	0.000155	CcSEcCtD
Perphenazine—Convulsion—Epirubicin—hematologic cancer	3.28e-05	0.000154	CcSEcCtD
Perphenazine—Infection—Methotrexate—hematologic cancer	3.28e-05	0.000154	CcSEcCtD
Perphenazine—Hypertension—Epirubicin—hematologic cancer	3.27e-05	0.000154	CcSEcCtD
Perphenazine—Agitation—Doxorubicin—hematologic cancer	3.22e-05	0.000152	CcSEcCtD
Perphenazine—Pruritus—Betamethasone—hematologic cancer	3.21e-05	0.000151	CcSEcCtD
Perphenazine—Pruritus—Dexamethasone—hematologic cancer	3.21e-05	0.000151	CcSEcCtD
Perphenazine—Dry mouth—Epirubicin—hematologic cancer	3.15e-05	0.000148	CcSEcCtD
Perphenazine—Anorexia—Methotrexate—hematologic cancer	3.15e-05	0.000148	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—hematologic cancer	3.14e-05	0.000148	CcSEcCtD
Perphenazine—Urticaria—Prednisone—hematologic cancer	3.14e-05	0.000148	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—hematologic cancer	3.13e-05	0.000148	CcSEcCtD
Perphenazine—Headache—Triamcinolone—hematologic cancer	3.13e-05	0.000147	CcSEcCtD
Perphenazine—Body temperature increased—Prednisone—hematologic cancer	3.12e-05	0.000147	CcSEcCtD
Perphenazine—Confusional state—Epirubicin—hematologic cancer	3.11e-05	0.000147	CcSEcCtD
Perphenazine—Diarrhoea—Betamethasone—hematologic cancer	3.1e-05	0.000146	CcSEcCtD
Perphenazine—Diarrhoea—Dexamethasone—hematologic cancer	3.1e-05	0.000146	CcSEcCtD
Perphenazine—Anaphylactic shock—Epirubicin—hematologic cancer	3.09e-05	0.000145	CcSEcCtD
Perphenazine—Hypotension—Methotrexate—hematologic cancer	3.08e-05	0.000145	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—hematologic cancer	3.08e-05	0.000145	CcSEcCtD
Perphenazine—Infection—Epirubicin—hematologic cancer	3.07e-05	0.000145	CcSEcCtD
Perphenazine—Cough—Doxorubicin—hematologic cancer	3.06e-05	0.000144	CcSEcCtD
Perphenazine—Shock—Epirubicin—hematologic cancer	3.04e-05	0.000143	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—hematologic cancer	3.03e-05	0.000143	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—hematologic cancer	3.02e-05	0.000142	CcSEcCtD
Perphenazine—Tachycardia—Epirubicin—hematologic cancer	3.01e-05	0.000142	CcSEcCtD
Perphenazine—Dizziness—Dexamethasone—hematologic cancer	3e-05	0.000141	CcSEcCtD
Perphenazine—Dizziness—Betamethasone—hematologic cancer	3e-05	0.000141	CcSEcCtD
Perphenazine—Insomnia—Methotrexate—hematologic cancer	2.99e-05	0.000141	CcSEcCtD
Perphenazine—Anorexia—Epirubicin—hematologic cancer	2.94e-05	0.000139	CcSEcCtD
Perphenazine—Dyspnoea—Methotrexate—hematologic cancer	2.94e-05	0.000139	CcSEcCtD
Perphenazine—Somnolence—Methotrexate—hematologic cancer	2.93e-05	0.000138	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—hematologic cancer	2.92e-05	0.000137	CcSEcCtD
Perphenazine—Hypersensitivity—Prednisone—hematologic cancer	2.91e-05	0.000137	CcSEcCtD
Perphenazine—Hypotension—Epirubicin—hematologic cancer	2.89e-05	0.000136	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—hematologic cancer	2.88e-05	0.000136	CcSEcCtD
Perphenazine—Decreased appetite—Methotrexate—hematologic cancer	2.87e-05	0.000135	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—hematologic cancer	2.86e-05	0.000135	CcSEcCtD
Perphenazine—Headache—Dexamethasone—hematologic cancer	2.84e-05	0.000134	CcSEcCtD
Perphenazine—Headache—Betamethasone—hematologic cancer	2.84e-05	0.000134	CcSEcCtD
Perphenazine—Infection—Doxorubicin—hematologic cancer	2.84e-05	0.000134	CcSEcCtD
Perphenazine—Chlorpromazine—ALB—hematologic cancer	2.83e-05	0.0105	CrCbGaD
Perphenazine—Pain—Methotrexate—hematologic cancer	2.82e-05	0.000133	CcSEcCtD
Perphenazine—Shock—Doxorubicin—hematologic cancer	2.81e-05	0.000132	CcSEcCtD
Perphenazine—Pruritus—Prednisone—hematologic cancer	2.79e-05	0.000132	CcSEcCtD
Perphenazine—Insomnia—Epirubicin—hematologic cancer	2.79e-05	0.000132	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—hematologic cancer	2.79e-05	0.000131	CcSEcCtD
Perphenazine—Dyspnoea—Epirubicin—hematologic cancer	2.75e-05	0.00013	CcSEcCtD
Perphenazine—Somnolence—Epirubicin—hematologic cancer	2.75e-05	0.000129	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—hematologic cancer	2.72e-05	0.000128	CcSEcCtD
Perphenazine—Chlorpromazine—ABCB1—hematologic cancer	2.7e-05	0.01	CrCbGaD
Perphenazine—Diarrhoea—Prednisone—hematologic cancer	2.7e-05	0.000127	CcSEcCtD
Perphenazine—Decreased appetite—Epirubicin—hematologic cancer	2.69e-05	0.000126	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—hematologic cancer	2.67e-05	0.000126	CcSEcCtD
Perphenazine—Pain—Epirubicin—hematologic cancer	2.64e-05	0.000124	CcSEcCtD
Perphenazine—Constipation—Epirubicin—hematologic cancer	2.64e-05	0.000124	CcSEcCtD
Perphenazine—Urticaria—Methotrexate—hematologic cancer	2.62e-05	0.000123	CcSEcCtD
Perphenazine—Dizziness—Prednisone—hematologic cancer	2.61e-05	0.000123	CcSEcCtD
Perphenazine—Body temperature increased—Methotrexate—hematologic cancer	2.61e-05	0.000123	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—hematologic cancer	2.58e-05	0.000122	CcSEcCtD
Perphenazine—Dyspnoea—Doxorubicin—hematologic cancer	2.55e-05	0.00012	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—hematologic cancer	2.54e-05	0.00012	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—hematologic cancer	2.48e-05	0.000117	CcSEcCtD
Perphenazine—Headache—Prednisone—hematologic cancer	2.47e-05	0.000117	CcSEcCtD
Perphenazine—Urticaria—Epirubicin—hematologic cancer	2.45e-05	0.000116	CcSEcCtD
Perphenazine—Pain—Doxorubicin—hematologic cancer	2.44e-05	0.000115	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—hematologic cancer	2.44e-05	0.000115	CcSEcCtD
Perphenazine—Body temperature increased—Epirubicin—hematologic cancer	2.44e-05	0.000115	CcSEcCtD
Perphenazine—Hypersensitivity—Methotrexate—hematologic cancer	2.43e-05	0.000115	CcSEcCtD
Perphenazine—Pruritus—Methotrexate—hematologic cancer	2.34e-05	0.00011	CcSEcCtD
Perphenazine—Hypersensitivity—Epirubicin—hematologic cancer	2.28e-05	0.000107	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—hematologic cancer	2.27e-05	0.000107	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—hematologic cancer	2.26e-05	0.000106	CcSEcCtD
Perphenazine—Diarrhoea—Methotrexate—hematologic cancer	2.26e-05	0.000106	CcSEcCtD
Perphenazine—Pruritus—Epirubicin—hematologic cancer	2.19e-05	0.000103	CcSEcCtD
Perphenazine—Dizziness—Methotrexate—hematologic cancer	2.18e-05	0.000103	CcSEcCtD
Perphenazine—Diarrhoea—Epirubicin—hematologic cancer	2.11e-05	9.95e-05	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—hematologic cancer	2.11e-05	9.92e-05	CcSEcCtD
Perphenazine—Headache—Methotrexate—hematologic cancer	2.07e-05	9.74e-05	CcSEcCtD
Perphenazine—Dizziness—Epirubicin—hematologic cancer	2.04e-05	9.62e-05	CcSEcCtD
Perphenazine—Pruritus—Doxorubicin—hematologic cancer	2.02e-05	9.52e-05	CcSEcCtD
Perphenazine—Diarrhoea—Doxorubicin—hematologic cancer	1.96e-05	9.21e-05	CcSEcCtD
Perphenazine—Headache—Epirubicin—hematologic cancer	1.94e-05	9.11e-05	CcSEcCtD
Perphenazine—Dizziness—Doxorubicin—hematologic cancer	1.89e-05	8.9e-05	CcSEcCtD
Perphenazine—Headache—Doxorubicin—hematologic cancer	1.79e-05	8.43e-05	CcSEcCtD
Perphenazine—CALM2—Disease—MYC—hematologic cancer	1.24e-06	7.92e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EP300—hematologic cancer	1.24e-06	7.91e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.24e-06	7.91e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—TGFB1—hematologic cancer	1.24e-06	7.91e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—TGFB1—hematologic cancer	1.24e-06	7.91e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PIK3CA—hematologic cancer	1.24e-06	7.9e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—EP300—hematologic cancer	1.24e-06	7.87e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.23e-06	7.84e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.23e-06	7.84e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	1.23e-06	7.84e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—SRC—hematologic cancer	1.23e-06	7.84e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.23e-06	7.83e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	1.23e-06	7.82e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.22e-06	7.76e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CB—hematologic cancer	1.21e-06	7.73e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MTOR—hematologic cancer	1.21e-06	7.73e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MTOR—hematologic cancer	1.21e-06	7.73e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CB—hematologic cancer	1.21e-06	7.73e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ALB—hematologic cancer	1.21e-06	7.73e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—SRC—hematologic cancer	1.21e-06	7.71e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—SRC—hematologic cancer	1.21e-06	7.7e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ALB—hematologic cancer	1.2e-06	7.66e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—hematologic cancer	1.2e-06	7.64e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.2e-06	7.63e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HRAS—hematologic cancer	1.2e-06	7.63e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—EP300—hematologic cancer	1.2e-06	7.62e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—EP300—hematologic cancer	1.2e-06	7.62e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	1.19e-06	7.58e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—hematologic cancer	1.19e-06	7.57e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	1.19e-06	7.57e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.19e-06	7.56e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.18e-06	7.54e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.18e-06	7.54e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PIK3CA—hematologic cancer	1.18e-06	7.53e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	1.18e-06	7.51e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1B—hematologic cancer	1.18e-06	7.5e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.18e-06	7.49e-06	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—hematologic cancer	1.18e-06	7.49e-06	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—hematologic cancer	1.18e-06	7.49e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	1.17e-06	7.44e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.17e-06	7.42e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	1.17e-06	7.42e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.16e-06	7.42e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.16e-06	7.4e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	1.16e-06	7.4e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.16e-06	7.39e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	1.16e-06	7.39e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	1.16e-06	7.38e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HRAS—hematologic cancer	1.16e-06	7.38e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HRAS—hematologic cancer	1.16e-06	7.38e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	1.15e-06	7.35e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CASP3—hematologic cancer	1.15e-06	7.35e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL2—hematologic cancer	1.15e-06	7.34e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.15e-06	7.33e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—hematologic cancer	1.15e-06	7.32e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—hematologic cancer	1.15e-06	7.32e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HRAS—hematologic cancer	1.15e-06	7.31e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—hematologic cancer	1.15e-06	7.3e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PIK3CA—hematologic cancer	1.14e-06	7.29e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PIK3CA—hematologic cancer	1.14e-06	7.29e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1B—hematologic cancer	1.14e-06	7.25e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1B—hematologic cancer	1.14e-06	7.25e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.13e-06	7.22e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	1.13e-06	7.22e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTEN—hematologic cancer	1.13e-06	7.18e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—hematologic cancer	1.12e-06	7.15e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—JUN—hematologic cancer	1.12e-06	7.14e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CASP3—hematologic cancer	1.12e-06	7.11e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CASP3—hematologic cancer	1.12e-06	7.11e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	1.12e-06	7.11e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL2—hematologic cancer	1.11e-06	7.1e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL2—hematologic cancer	1.11e-06	7.1e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	1.11e-06	7.09e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—hematologic cancer	1.11e-06	7.06e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—hematologic cancer	1.11e-06	7.06e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—hematologic cancer	1.1e-06	7.02e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	1.1e-06	7.02e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.1e-06	7.01e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.1e-06	6.99e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—hematologic cancer	1.1e-06	6.99e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HRAS—hematologic cancer	1.09e-06	6.97e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—PIK3CA—hematologic cancer	1.09e-06	6.95e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.09e-06	6.93e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1A—hematologic cancer	1.09e-06	6.92e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—hematologic cancer	1.09e-06	6.92e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—hematologic cancer	1.09e-06	6.92e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—hematologic cancer	1.09e-06	6.91e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—JUN—hematologic cancer	1.08e-06	6.9e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—JUN—hematologic cancer	1.08e-06	6.9e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PTEN—hematologic cancer	1.08e-06	6.9e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—hematologic cancer	1.08e-06	6.9e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	1.08e-06	6.89e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.08e-06	6.88e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—EP300—hematologic cancer	1.08e-06	6.85e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	1.07e-06	6.83e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.07e-06	6.82e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.07e-06	6.79e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	1.06e-06	6.77e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.06e-06	6.76e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	1.06e-06	6.76e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK8—hematologic cancer	1.06e-06	6.75e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	1.06e-06	6.75e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HRAS—hematologic cancer	1.06e-06	6.74e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HRAS—hematologic cancer	1.06e-06	6.74e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—hematologic cancer	1.06e-06	6.73e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—PIK3CA—hematologic cancer	1.06e-06	6.73e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—PIK3CA—hematologic cancer	1.06e-06	6.73e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1A—hematologic cancer	1.05e-06	6.69e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1A—hematologic cancer	1.05e-06	6.69e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTEN—hematologic cancer	1.05e-06	6.68e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTEN—hematologic cancer	1.05e-06	6.68e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—hematologic cancer	1.05e-06	6.67e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.04e-06	6.63e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EP300—hematologic cancer	1.03e-06	6.58e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—hematologic cancer	1.03e-06	6.57e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ALB—hematologic cancer	1.03e-06	6.55e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—hematologic cancer	1.03e-06	6.54e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK8—hematologic cancer	1.03e-06	6.53e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK8—hematologic cancer	1.03e-06	6.53e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—hematologic cancer	1.02e-06	6.51e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—hematologic cancer	1.02e-06	6.51e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.02e-06	6.49e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	1.02e-06	6.46e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—hematologic cancer	1.01e-06	6.45e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—hematologic cancer	1.01e-06	6.45e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—hematologic cancer	1.01e-06	6.45e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—HRAS—hematologic cancer	1.01e-06	6.43e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.01e-06	6.41e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SRC—hematologic cancer	1.01e-06	6.4e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	1e-06	6.39e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	1e-06	6.38e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—hematologic cancer	1e-06	6.37e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EP300—hematologic cancer	1e-06	6.37e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EP300—hematologic cancer	1e-06	6.37e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	9.87e-07	6.29e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	9.87e-07	6.28e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	9.85e-07	6.27e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	9.83e-07	6.26e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	9.82e-07	6.25e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—hematologic cancer	9.79e-07	6.24e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—HRAS—hematologic cancer	9.77e-07	6.22e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—HRAS—hematologic cancer	9.77e-07	6.22e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SRC—hematologic cancer	9.72e-07	6.19e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SRC—hematologic cancer	9.72e-07	6.19e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—STAT3—hematologic cancer	9.7e-07	6.17e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NRAS—hematologic cancer	9.67e-07	6.16e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—hematologic cancer	9.67e-07	6.16e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—hematologic cancer	9.66e-07	6.15e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—EP300—hematologic cancer	9.6e-07	6.11e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—hematologic cancer	9.47e-07	6.03e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—hematologic cancer	9.47e-07	6.03e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—hematologic cancer	9.44e-07	6.01e-06	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	9.4e-07	5.98e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—hematologic cancer	9.39e-07	5.98e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—STAT3—hematologic cancer	9.38e-07	5.97e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—STAT3—hematologic cancer	9.38e-07	5.97e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	9.36e-07	5.96e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NRAS—hematologic cancer	9.36e-07	5.96e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NRAS—hematologic cancer	9.36e-07	5.96e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—hematologic cancer	9.35e-07	5.96e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—hematologic cancer	9.35e-07	5.96e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—hematologic cancer	9.35e-07	5.95e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—hematologic cancer	9.35e-07	5.95e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK3—hematologic cancer	9.26e-07	5.9e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTEN—hematologic cancer	9.26e-07	5.9e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	9.21e-07	5.87e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	9.19e-07	5.85e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTEN—hematologic cancer	9.18e-07	5.84e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PIK3CA—hematologic cancer	9.15e-07	5.82e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	9.14e-07	5.82e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	9.12e-07	5.81e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	9.08e-07	5.78e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—hematologic cancer	9.06e-07	5.77e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—hematologic cancer	9.01e-07	5.74e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TGFB1—hematologic cancer	8.99e-07	5.72e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK3—hematologic cancer	8.96e-07	5.71e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK3—hematologic cancer	8.96e-07	5.71e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—hematologic cancer	8.92e-07	5.68e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—hematologic cancer	8.91e-07	5.68e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—hematologic cancer	8.89e-07	5.66e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PIK3CA—hematologic cancer	8.85e-07	5.63e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PIK3CA—hematologic cancer	8.85e-07	5.63e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—EP300—hematologic cancer	8.83e-07	5.62e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—EP300—hematologic cancer	8.75e-07	5.57e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—hematologic cancer	8.71e-07	5.55e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—hematologic cancer	8.71e-07	5.55e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	8.71e-07	5.55e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TGFB1—hematologic cancer	8.69e-07	5.54e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TGFB1—hematologic cancer	8.69e-07	5.54e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	8.67e-07	5.52e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRAS—hematologic cancer	8.66e-07	5.52e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—hematologic cancer	8.63e-07	5.5e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—hematologic cancer	8.63e-07	5.5e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	8.52e-07	5.43e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRAS—hematologic cancer	8.51e-07	5.42e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CREBBP—hematologic cancer	8.48e-07	5.4e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	8.38e-07	5.34e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—hematologic cancer	8.32e-07	5.3e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—hematologic cancer	8.29e-07	5.28e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—hematologic cancer	8.19e-07	5.21e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—hematologic cancer	8.16e-07	5.19e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—hematologic cancer	8.14e-07	5.18e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	8.11e-07	5.16e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—hematologic cancer	8.05e-07	5.13e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—hematologic cancer	8.05e-07	5.13e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	8.04e-07	5.12e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	7.96e-07	5.07e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ALB—hematologic cancer	7.93e-07	5.05e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTEN—hematologic cancer	7.84e-07	4.99e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	7.75e-07	4.94e-06	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—hematologic cancer	7.68e-07	4.89e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—hematologic cancer	7.65e-07	4.87e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CA—hematologic cancer	7.65e-07	4.87e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	7.59e-07	4.83e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	7.53e-07	4.79e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—hematologic cancer	7.51e-07	4.78e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—EP300—hematologic cancer	7.48e-07	4.76e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—hematologic cancer	7.47e-07	4.76e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	7.42e-07	4.73e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—hematologic cancer	7.4e-07	4.71e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CA—hematologic cancer	7.4e-07	4.71e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CA—hematologic cancer	7.4e-07	4.71e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—hematologic cancer	7.23e-07	4.6e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—hematologic cancer	7.23e-07	4.6e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—hematologic cancer	7.16e-07	4.56e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—hematologic cancer	7.16e-07	4.56e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	7.1e-07	4.52e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRAS—hematologic cancer	7.08e-07	4.51e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.01e-07	4.46e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	6.85e-07	4.36e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRAS—hematologic cancer	6.84e-07	4.36e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRAS—hematologic cancer	6.84e-07	4.36e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—hematologic cancer	6.77e-07	4.31e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—hematologic cancer	6.55e-07	4.17e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—hematologic cancer	6.55e-07	4.17e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	6.53e-07	4.16e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—hematologic cancer	6.5e-07	4.14e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	6.48e-07	4.12e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—hematologic cancer	6.25e-07	3.98e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTEN—hematologic cancer	6.05e-07	3.85e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—hematologic cancer	6.04e-07	3.85e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—hematologic cancer	6.04e-07	3.85e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—hematologic cancer	5.8e-07	3.69e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—EP300—hematologic cancer	5.77e-07	3.68e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	5.53e-07	3.52e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—hematologic cancer	5.34e-07	3.4e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—hematologic cancer	5.29e-07	3.37e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—hematologic cancer	4.52e-07	2.88e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.27e-07	2.72e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—hematologic cancer	3.49e-07	2.22e-06	CbGpPWpGaD
